First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - FDA DEVELOPMENTS LIMITED

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: FDA DEVELOPMENTS LIMITED, The Garden Suite 23 Westfield Park, Redland, Bristol, BS6 6LT. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 July 2022. The company was incorporated on 18 January 2018.

The accounts next due date is 30 April 2024. There are 3 mortgages, none satisfied, none part satisfied and 3 unsatisfied.

The above was based on public record information as at 30 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 11157323
Date Incorporated: 18 January 2018
Date Latest Accounts: 31 July 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 11157323
Annual Return: Unknown
Registered Office: The Garden Suite 23 Westfield Park, Redland, Bristol, BS6 6LT
SIC Code and Operations: 68100
SECURED CREDITORS
Number of Mortgages 3
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 3
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

FDA DEVELOPMENTS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 9 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
10853842 FDA DISTRIBUTION LIMITED Active - Proposal to Strike off
08842076 FDA DRIVER SERVICES LTD Dissolved
15028482 FDA GLOBAL MANAGEMENT LTD Active
12666540 FDA GLOBAL TRADE LTD Active
12196315 FDA GROUP LTD Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd